Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Liebert

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Blood group antigens and integrins as biomarkers in head and neck cancer: is aberrant tyrosine phosphorylation the cause of altered alpha 6 beta 4 integrin expression?T E Carey, T S Nair, C Chern, et al.
Cancer Research|December 1, 1989
Identification by monoclonal antibodies of an antigen shed by human bladder cancer cellsM Liebert, G A Wedemeyer, J A Stein, et al.
Advances in Therapy|January 10, 2018
Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational StudyShaloo Gupta, Hongwei Wang, Neil Skolnik, et al.
The Journal of Urology|September 1, 1997
Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladderJ W Slaton, C P Dinney, R W Veltri, et al.
Molecular and Cellular Biology|July 1, 1991
Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cellsM D Sklar, E Thompson, M J Welsh, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trialsG P Hemstreet, J Rao, R E Hurst, et al.
The American Journal of Pathology|February 1, 1992
Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomasL V Abruzzo, A J Thornton, M Liebert, et al.
Journal of the National Cancer Institute|January 1, 1987
Products of cells cultured from gliomas. V. Cytology and morphometry of two cell types cultured from gliomaP E McKeever, T W Hood, J Varani, et al.
Cancer Research|January 1, 1997
Beta 4 integrin transfection of UM-UC-2 (human bladder carcinoma) cells: stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact beta 4S Y Kim, N J Bachman, T S Nair, et al.
Cancer Research|July 15, 1997
CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: evidence for a role in regenerative differentiationL Xia, S W Stoll, M Liebert, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cellular Biochemistry. Supplement|January 1, 1993
Blood group antigens and integrins as biomarkers in head and neck cancer: is aberrant tyrosine phosphorylation the cause of altered alpha 6 beta 4 integrin expression?T E Carey, T S Nair, C Chern, et al.
Cancer Research|December 1, 1989
Identification by monoclonal antibodies of an antigen shed by human bladder cancer cellsM Liebert, G A Wedemeyer, J A Stein, et al.
Advances in Therapy|January 10, 2018
Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational StudyShaloo Gupta, Hongwei Wang, Neil Skolnik, et al.
The Journal of Urology|September 1, 1997
Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladderJ W Slaton, C P Dinney, R W Veltri, et al.
Molecular and Cellular Biology|July 1, 1991
Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cellsM D Sklar, E Thompson, M J Welsh, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trialsG P Hemstreet, J Rao, R E Hurst, et al.
The American Journal of Pathology|February 1, 1992
Cytokine-induced gene expression of interleukin-8 in human transitional cell carcinomas and renal cell carcinomasL V Abruzzo, A J Thornton, M Liebert, et al.
Journal of the National Cancer Institute|January 1, 1987
Products of cells cultured from gliomas. V. Cytology and morphometry of two cell types cultured from gliomaP E McKeever, T W Hood, J Varani, et al.
Cancer Research|January 1, 1997
Beta 4 integrin transfection of UM-UC-2 (human bladder carcinoma) cells: stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact beta 4S Y Kim, N J Bachman, T S Nair, et al.
Cancer Research|July 15, 1997
CaN19 expression in benign and malignant hyperplasias of the skin and oral mucosa: evidence for a role in regenerative differentiationL Xia, S W Stoll, M Liebert, et al.
Pageof 8